Bio-Images and Medimetrics Partner to Deliver the Next Generation of Smart Pill Technology
Bio-Images Research and Medimetrics Personalized Drug Delivery have today announced a partnership to introduce the IntelliCap to the global pharmaceutical industry as a clinical research tool.
Read more ...
Innovative technology improves care and reduces costs
The use of long-distance video and data hookups to link remote community hospitals with stroke neurologists in large centres provides the same level of care as having everyone in the same room, according to a new study presented today at the Canadian Stroke Congress.
Read more ...
ecancerHub - A New Approach to Cancer Communication
eurocancercoms has announced the launch of ecancerHub - a new, open-access, integrated approach to providing the whole cancer community - patients, doctors, researchers and policymakers - with high quality and trustworthy information.
Read more ...
Based on the recommendations of the IMI Research Agenda, the IMI Governing Board has approved the IMI Annual Implementation Plan 2011, including the Scientific Priorities 2011. These priorities have been incorporated into the IMI 4th Call Topics.
Read more ...
ASCO Launches Cancer.Net Mobile, a New App for iPhone, iPad, and iPod Touch
The American Society of Clinical Oncology (ASCO), the world's leading professional organization representing cancer physicians, released Cancer.Net Mobile for the iPhone, iPad, and iPod Touch - a free app designed by oncologists to help people with cancer and their caregivers plan and manage cancer treatment and care.
Read more ...
Harvard Medical School Faculty Advances Drug Safety Research with IBM Business Analytics
IBM (NYSE: IBM) announced that faculty from Harvard Medical School and Brigham & Women's Hospital will use IBM business analytics technology at the core of new research that examines the effectiveness of prescription drugs and spots potential safety issues.
Read more ...
New potential drug targets discovered for preventing prostate cancer cell growth
Researchers from VTT Technical Research Centre of Finland and the University of Turku have discovered four metabolic enzymes regulating prostate cancer cell growth. Inhibition of these enzymes prevents prostate cancer cell growth in cultured cells.
Read more ...